Pauline du Rusquec

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson, Alexandre Maria, F. Poizeau et al. · Journal for ImmunoTherapy of Cancer · 2019 · 106 citations · Full text

Life Sciences, Immunology, Oncology +17

Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer

Éric Voog, L. Campion, Pauline du Rusquec et al. · Supportive Care in Cancer · 2017 · 77 citations

Medicine, Oncology, Surgery +17

Ipilimumab-induced Autoimmune Pancytopenia in a Case of Metastatic Melanoma

Pauline du Rusquec, M. Saint‐Jean, A. Brocard et al. · Journal of Immunotherapy · 2014 · 44 citations

Life Sciences, Hematology, Oncology +16

Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer

Pauline du Rusquec, Clément Palpacuer, L. Campion et al. · Breast Cancer Research and Treatment · 2017 · 34 citations

Medicine, Oncology, Pharmacology +12

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial

István Peták, Maud Kamal, Anna Dirner et al. · npj Precision Oncology · 2021 · 27 citations · Full text

Medicine, Bioinformatics, Oncology +17